Publications by authors named "Ruyu Han"

Claim this Profile
P
Perioperative and precision strategies in resectable intrahepatic cholangiocarcinoma.
Lu Chen, Ruyu Han, Tianqiang Song, Peipei Song, Wei Tang

Glob Health Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival benefit of adjuvant chemotherapy and individualized prognosis in resected cHCC-CCA.
Bo Sun, Yimeng Wang, Ruyu Han, Yuren Xia, Meng Zhao

Biosci Trends· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized Prediction of Postoperative Survival in Gallbladder Cancer: A Nomogram Based on SEER Data and External Validation.
Yayue Liu, Kangwei Zhu, Xindi Tian, Ping Chen, Qingqing Xiong, Ruyu Han

Cancers (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib combined with TACE improves survival in patients with hepatocellular carcinoma with vascular invasion.
Zhiqiang Han, Ruyu Han, Yimeng Wang, Kangwei Zhu, Xiangdong Tian

Biosci Trends· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib, sintilimab combined interventional treatment bevacizumab, sintilimab combined interventional treatment for intermediate-advanced unresectable hepatocellular carcinoma.
Ru-Yu Han, Lei-Juan Gan, Meng-Ran Lang, Shao-Hua Ren, Dong-Ming Liu

World J Gastroenterol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score-Matched Study.
Ruyu Han, Leijuan Gan, Liyu Sun, Mengran Lang, Xindi Tian

J Hepatocell Carcinoma· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital communication activities and EFL learners' willingness to communicate and engagement: Exploring the intermediate language learners' perceptions.
Ruyu Han, Goudarz Alibakhshi, Lu Lu, Akram Labbafi

Heliyon· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Study on Predicting Recurrence of Intermediate-Stage Hepatocellular Carcinoma After Radical Therapy.
Ruyu Han, Leijuan Gan, Mengran Lang, Guangtao Li, Lu Chen

J Hepatocell Carcinoma· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and therapeutic perspectives of differentiation-inducing therapy in malignant tumors.
Kangwei Zhu, Yuren Xia, Xindi Tian, Yuchao He, Jun Zhou, Ruyu Han

Front Genet· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib plus sintilimab with or without transarterial chemoembolization for intermediate or advanced stage hepatocellular carcinoma: a propensity score-matching cohort study.
Mengran Lang, Leijuan Gan, Shaohua Ren, Ruyu Han, Xiaochen Ma, Ti Zhang, Wei Zhang

Am J Cancer Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma.
Leijuan Gan, Mengran Lang, Xindi Tian, Shaohua Ren, Guangtao Li, Ruyu Han, Wei Zhang

J Hepatocell Carcinoma· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Value of Preoperative Serum AFP, CEA, and CA19-9 Levels in Patients with Single Small Hepatocellular Carcinoma: Retrospective Study.
Leijuan Gan, Shaohua Ren, Mengran Lang, Guangtao Li, Feng Fang, Ruyu Han

J Hepatocell Carcinoma· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis